BioAmber Inc.
BIOA
BIOA was delisted on the 8th of February, 2018.
34 hedge funds and large institutions have $58.1M invested in BioAmber Inc. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 6 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
8% less funds holding
Funds holding: 37 → 34 (-3)
36% less capital invested
Capital invested by funds: $91.3M → $58.1M (-$33.2M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$604K |
| 2 |
RA
Royce & Associates
New York
|
+$476K |
| 3 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$275K |
| 4 |
LPL Financial
San Diego,
California
|
+$245K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$365K |
| 2 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$264K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$136K |
| 4 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$34K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$29K |
BIOA Hedge Fund Activity: Q3 2015 in Review
34 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q3 2015, worth a combined $58.1M — down 36% from $91.3M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BIOA and 3 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 12 added.
The largest buyer was Baillie Gifford & Co, adding an estimated $604K. The largest seller was Alyeska Investment Group, cutting an estimated $365K.
- 34 institutional investors held BioAmber Inc. (BIOA) as of Q3 2015, down from 37 in Q2 2015.
- Funds reported $58.1M of BioAmber Inc. stock for Q3 2015, down 36% quarter-over-quarter.
- 3 funds opened new BioAmber Inc. positions in Q3 2015 and 6 closed out, a net change of -3 holders.
- The largest BioAmber Inc. buyer in Q3 2015 was Baillie Gifford & Co, an estimated $604K added.
- The largest BioAmber Inc. seller in Q3 2015 was Alyeska Investment Group, an estimated $365K sold.
Based on aggregated 13F filings for Q3 2015.